Drugs / Medroxyprogesterone Acetate (MPA)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00997893 Background | Dec 2009 → May 2015 | — | University of Illinois at Chicago | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Medroxyprogesterone Acetate (MPA) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00997893 ↗ |
| Route | Oral | “10 mg/d oral medroxyprogesterone acetate (MPA) pill” NCT00997893 ↗ |